SCHEMBL4284962

SCHEMBL4284962

CC(C)CCOc1ccc(C(=O)c2ccc(OCCC(C)C)c(OCC(=O)O)c2)c(OCCC(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.50
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ PPARD Q03181 3/20 0.41
▸ PPARG P37231 2/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CYSLTR2 Q9NS75 1/20 0.41
▸ CYSLTR1 Q9Y271 1/20 0.41
▸ RARB P10826 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ FOS P01100 1/20 0.39
▸ JUN P05412 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4289733 0.94 FOS (0.48) MAPK1MEN1KMT2ALMNAPPARD
SCHEMBL4277481 0.87 HPGD (0.47) MAPK1KMT2ALMNAPOLBCASP6
SCHEMBL4279733 0.86 FOS (0.54) MEN1KMT2ALMNAPPARDPOLB
SCHEMBL4289725 0.81 HPGD (0.44) MAPK1KMT2ALMNAPOLBCASP6
SCHEMBL4279655 0.78 FOS (0.56) MAPK1PPARDPPARGPPARANR1H4
SCHEMBL4276633 0.76 MAPK1 (0.64) MAPK1POLBCASP6NR1H4ALDH1A1
SCHEMBL4853208 0.75 FOS (0.48) MAPK1LMNAPOLBCASP6ALDH1A1
SCHEMBL4284432 0.73 HPGD (0.49) MEN1KMT2ALMNAPOLBALDH1A1
SCHEMBL4289851 0.73 LMNA (0.46) MAPK1LMNAPOLBCASP6NR1H4
SCHEMBL4279133 0.72 FOS (0.49) MAPK1POLBNR1H4ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 — — US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 — — US disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 MAPK1 763/4885MEN1 2341/4885KMT2A 3804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback